EUVIMEDEUVIMED entdecken
Open Access

Human stem cell-specific epigenetic signatures control transgene expression

Chulhwan S Kwak, Furkan E Oflaz, Jiamin Qiu, Xinnan Wang

Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 2024

DOI: 10.1016/j.bbagrm.2024.195063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2024. Verfasst von Chulhwan S Kwak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Promoter Regions, Genetic, DNA Methylation, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, Stanford University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human stem cell-derived models have emerged as an important platform to study tissue differentiation and disease mechanisms. Those models could capitalize on biochemical and cell biological methodologies such as omics, autophagy, and organelle dynamics. However, epigenetic silencing in stem cells creates a barrier to apply genetically encoded tools. Here we investigate the molecular mechanisms underlying exogenously expressed gene silencing by employing multiple commonly used promoters in human induced pluripotent stem cells (iPSCs), glioblastoma cells (GBM), and embryonic kidney cells (HEK). We discover that all promoters tested are highly methylated on the CpG island regions with lower protein expression in iPSCs, as compared to non-iPSCs. Elongation factor 1 alpha short (EF1α short or EFS) promoter, which has fewer CpG island number compared to the other promoters, can drive relatively higher gene expression in iPSCs, despite CpG methylation. Adding a minimal A2 ubiquitous chromatin opening element (minimal A2 UCOE or miniUCOE) upstream of a promoter inhibits CpG methylation and enhances gene expression in iPSCs. Our results demonstrate stem cell type-specific epigenetic modification of transgenic promoter region and provide useful information for designing anti-silencing strategies to increase transgene expression in iPSCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticPromoter Regions, GeneticDNA MethylationInduced Pluripotent Stem CellsTransgenesCpG IslandsHumansHEK293 CellsGene SilencingGlioblastomaPeptide Elongation Factor 1Cell Line, Tumor

Stichwörter der Autor:innen

Gene expressionMethylationPromoterSilenceiPSCs

Substanzen

Peptide Elongation Factor 1

Autor:innen und Institutionen

  • Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: xinnanw@stanford.edu.

Förderung

  • NIGMS NIH HHS
  • NINDS NIH HHS
  • Stanford University
  • National Institute of Neurological Disorders and Stroke
  • National Institute of General Medical Sciences

Zitieren

APA

Kwak, C. S., Oflaz, F. E., Qiu, J., & Wang, X. (2024). Human stem cell-specific epigenetic signatures control transgene expression. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. https://doi.org/10.1016/j.bbagrm.2024.195063

Vancouver

Kwak CS, Oflaz FE, Qiu J, Wang X. Human stem cell-specific epigenetic signatures control transgene expression. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 2024. doi:10.1016/j.bbagrm.2024.195063

BibTeX
@article{Kwak2024,
  author = {Kwak, Chulhwan S and Oflaz, Furkan E and Qiu, Jiamin and Wang, Xinnan},
  title = {Human stem cell-specific epigenetic signatures control transgene expression},
  journal = {Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms},
  year = {2024},
  doi = {10.1016/j.bbagrm.2024.195063}
}
Kostenlos starten →